- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.12. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan | 1 | GlobeNewswire (USA) | ||
| 15.12. | Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST | 1 | GlobeNewswire (USA) | ||
| 05.12. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11. | Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans | 1 | Seeking Alpha | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 19.11. | Vivos Therapeutics GAAP EPS of -$0.49, revenue of $6.8M | 4 | Seeking Alpha | ||
| 19.11. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 | 326 | GlobeNewswire (Europe) | Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference... ► Artikel lesen | |
| 19.11. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.11. | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11. | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 04.11. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.10. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09. | Vivos Therapeutics, Inc: Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device | 221 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 17.09. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment | 192 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 12.09. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.08. | Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M | 3 | Seeking Alpha | ||
| 19.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update | 250 | GlobeNewswire (Europe) | Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' differentiated array of highly effective OSA treatments... ► Artikel lesen | |
| 19.08. | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 30.07. | Vivos Therapeutics appoints two executives to support growth strategy | 3 | Investing.com | ||
| 30.07. | Vivos Therapeutics, Inc: Vivos Therapeutics Adds to Management Team to Support Expansion and Growth | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,970 | +2,39 % | Morgen-Update: Eckert&Ziegler schockt die Skeptiker - Kurs geht durch die Decke! | ||
| SERNOVA BIOTHERAPEUTICS | 0,082 | +3,16 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,016 | -11,11 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| PLUS THERAPEUTICS | 0,580 | +2,08 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ in Leptomeningeal Metastases | HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| CARDINAL HEALTH | 173,65 | -0,54 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,600 | -0,83 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,098 | +0,31 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen VIVOS THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,035 Euro und damit -1,21 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.